Mike Kratky
Stock Analyst at Leerink Partners
(4.28)
# 1,372
Out of 4,504 analysts
264
Total ratings
44.1%
Success rate
13.1%
Average return
Main Sectors:
Stocks Rated by Mike Kratky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintained: Buy | n/a | $83.87 | - | 8 | Jul 10, 2026 | |
| EW Edwards Lifesciences | Rated: Hold | $84 → $87 | $92.21 | -5.65% | 31 | Jun 16, 2026 | |
| PRCT PROCEPT BioRobotics | Downgraded: Hold | $65 → $29 | $20.89 | +38.82% | 19 | Jun 12, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $89 → $74 | $44.77 | +65.29% | 8 | May 28, 2026 | |
| SYK Stryker | Initiated Coverage: Buy | $410 | $329.78 | +24.33% | 1 | Apr 13, 2026 | |
| ZBH Zimmer Biomet Holdings | Initiated Coverage: Hold | $101 | $91.34 | +10.58% | 1 | Apr 13, 2026 | |
| PEN Penumbra | Downgraded: Hold | $327 → $374 | $318.10 | +17.57% | 8 | Jan 15, 2026 | |
| ISRG Intuitive Surgical | Reiterated: Buy | $600 | $406.78 | +47.50% | 22 | Oct 22, 2025 | |
| ABT Abbott Laboratories | Reiterated: Hold | $136 | $93.93 | +44.79% | 4 | Oct 16, 2025 | |
| VCEL Vericel | Maintained: Buy | $50 → $48 | $47.00 | +2.13% | 18 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 → $84 | $74.96 | +12.06% | 21 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $333 → $355 | $161.28 | +120.11% | 15 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $29 | $15.41 | +88.19% | 17 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $96 | $51.76 | +85.47% | 28 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $52.47 | - | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $17.03 | +64.42% | 5 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $40.58 | -45.79% | 17 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $18 | $17.11 | +5.20% | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $256.98 | n/a | 1 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,188.58 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $46 | $1.12 | n/a | 11 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $31 | $119.35 | n/a | 10 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $19.74 | n/a | 1 | Aug 15, 2022 |
Medtronic
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $83.87
Upside: -
Edwards Lifesciences
Jun 16, 2026
Rated: Hold
Price Target: $84 → $87
Current: $92.21
Upside: -5.65%
PROCEPT BioRobotics
Jun 12, 2026
Downgraded: Hold
Price Target: $65 → $29
Current: $20.89
Upside: +38.82%
Boston Scientific
May 28, 2026
Maintained: Buy
Price Target: $89 → $74
Current: $44.77
Upside: +65.29%
Stryker
Apr 13, 2026
Initiated Coverage: Buy
Price Target: $410
Current: $329.78
Upside: +24.33%
Zimmer Biomet Holdings
Apr 13, 2026
Initiated Coverage: Hold
Price Target: $101
Current: $91.34
Upside: +10.58%
Penumbra
Jan 15, 2026
Downgraded: Hold
Price Target: $327 → $374
Current: $318.10
Upside: +17.57%
Intuitive Surgical
Oct 22, 2025
Reiterated: Buy
Price Target: $600
Current: $406.78
Upside: +47.50%
Abbott Laboratories
Oct 16, 2025
Reiterated: Hold
Price Target: $136
Current: $93.93
Upside: +44.79%
Vericel
Oct 14, 2025
Maintained: Buy
Price Target: $50 → $48
Current: $47.00
Upside: +2.13%
Oct 14, 2025
Maintained: Buy
Price Target: $101 → $84
Current: $74.96
Upside: +12.06%
Oct 14, 2025
Maintained: Buy
Price Target: $333 → $355
Current: $161.28
Upside: +120.11%
Oct 14, 2025
Maintained: Buy
Price Target: $32 → $29
Current: $15.41
Upside: +88.19%
Oct 14, 2025
Maintained: Hold
Price Target: $96
Current: $51.76
Upside: +85.47%
Oct 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $52.47
Upside: -
Sep 12, 2025
Reiterated: Buy
Price Target: $28
Current: $17.03
Upside: +64.42%
Aug 25, 2025
Maintained: Buy
Price Target: $22
Current: $40.58
Upside: -45.79%
Aug 13, 2025
Reiterated: Buy
Price Target: $17 → $18
Current: $17.11
Upside: +5.20%
Apr 5, 2024
Maintained: Buy
Price Target: n/a
Current: $256.98
Upside: n/a
Oct 16, 2023
Maintained: Buy
Price Target: n/a
Current: $1,188.58
Upside: n/a
Sep 26, 2023
Maintained: Buy
Price Target: $45 → $46
Current: $1.12
Upside: n/a
May 4, 2023
Reiterated: Hold
Price Target: $31
Current: $119.35
Upside: n/a
Aug 15, 2022
Maintained: Buy
Price Target: $40
Current: $19.74
Upside: n/a